Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: ACS Infect Dis. 2016 Dec 5;3(2):176–181. doi: 10.1021/acsinfecdis.6b00172

Figure 3.

Figure 3

Evaluating the cell permeability and activity of selective Mtb 20S inhibitors using M. bovis BCG. Apparent activity reflects proteasome-activity observed in lysates from the treated and untreated cultures. The proteasome activity observed in the untreated sample was set as 100%. The experiments were performed in triplicate. See supporting information for experimental protocols.